93 related articles for article (PubMed ID: 8573379)
1. Intracellular activation and cytotoxicity of three different combinations of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine.
Palmer S; Cox S
AIDS Res Hum Retroviruses; 1995 Oct; 11(10):1227-33. PubMed ID: 8573379
[TBL] [Abstract][Full Text] [Related]
2. In vitro analysis of synergism and antagonism of different nucleoside/nucleotide analogue combinations on the inhibition of human immunodeficiency virus type 1 replication.
Perez-Olmeda M; Garcia-Perez J; Mateos E; Spijkers S; Ayerbe MC; Carcas A; Alcami J
J Med Virol; 2009 Feb; 81(2):211-6. PubMed ID: 19107982
[TBL] [Abstract][Full Text] [Related]
3. Intracellular activation of 2',3'-dideoxyinosine and drug interactions in vitro.
Kewn S; Hoggard PG; Henry-Mowatt JS; Veal GJ; Sales SD; Barry MG; Back DJ
AIDS Res Hum Retroviruses; 1999 Jun; 15(9):793-802. PubMed ID: 10381167
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of mutations at the HPRT and TK loci of human lymphoblastoid cells after combined treatments with 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosinedagger.
Meng Q; Su T; O'Neill JP; Walker VE
Environ Mol Mutagen; 2002; 39(4):282-95. PubMed ID: 12112380
[TBL] [Abstract][Full Text] [Related]
5. Comparative metabolism of the antiviral dimer 3'-azido-3'-deoxythymidine-P-2',3'-dideoxyinosine and the monomers zidovudine and didanosine by rat, monkey, and human hepatocytes.
Pan-Zhou XR; Cretton-Scott E; Zhou XJ; Xie MY; Rahmani R; Schinazi RF; Duchin K; Sommadossi JP
Antimicrob Agents Chemother; 1997 Nov; 41(11):2502-10. PubMed ID: 9371357
[TBL] [Abstract][Full Text] [Related]
6. The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites.
Barry MG; Khoo SH; Veal GJ; Hoggard PG; Gibbons SE; Wilkins EG; Williams O; Breckenridge AM; Back DJ
AIDS; 1996 Oct; 10(12):1361-7. PubMed ID: 8902065
[TBL] [Abstract][Full Text] [Related]
7. Effects of dideoxyinosine and dideoxycytidine on the intracellular phosphorylation of zidovudine in human mononuclear cells.
Veal GJ; Wild MJ; Barry MG; Back DJ
Br J Clin Pharmacol; 1994 Oct; 38(4):323-8. PubMed ID: 7833221
[TBL] [Abstract][Full Text] [Related]
8. Effect of ribavirin on zidovudine efficacy and toxicity in vitro: a concentration-dependent interaction.
Sim SM; Hoggard PG; Sales SD; Phiboonbanakit D; Hart CA; Back DJ
AIDS Res Hum Retroviruses; 1998 Dec; 14(18):1661-7. PubMed ID: 9870320
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in patients with the acquired immunodeficiency syndrome.
Barry M; Howe JL; Ormesher S; Back DJ; Breckenridge AM; Bergin C; Mulcahy F; Beeching N; Nye F
Br J Clin Pharmacol; 1994 May; 37(5):421-6. PubMed ID: 8054247
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human immunodeficiency virus type 1 infection in vitro by combination of delavirdine, zidovudine and didanosine.
Chong KT; Pagano PJ
Antiviral Res; 1997 Mar; 34(1):51-63. PubMed ID: 9107385
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic assay for measurement of zidovudine triphosphate in peripheral blood mononuclear cells.
Robbins BL; Rodman J; McDonald C; Srinivas RV; Flynn PM; Fridland A
Antimicrob Agents Chemother; 1994 Jan; 38(1):115-21. PubMed ID: 7511360
[TBL] [Abstract][Full Text] [Related]
12. Didanosine.
Shelton MJ; O'Donnell AM; Morse GD
Ann Pharmacother; 1992 May; 26(5):660-70. PubMed ID: 1350471
[TBL] [Abstract][Full Text] [Related]
13. Intracellular zidovudine (ZDV) and ZDV phosphates as measured by a validated combined high-pressure liquid chromatography-radioimmunoassay procedure.
Slusher JT; Kuwahara SK; Hamzeh FM; Lewis LD; Kornhauser DM; Lietman PS
Antimicrob Agents Chemother; 1992 Nov; 36(11):2473-7. PubMed ID: 1489190
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of genetic toxicity of AZT and ddI antiretrovirals in somatic cells of Drosophila melanogaster.
GuimarĂ£es NN; de Castro Pereira K; de Andrade HH; Lehmann M; Silva Cunha K
Environ Mol Mutagen; 2008 May; 49(4):312-7. PubMed ID: 18366095
[TBL] [Abstract][Full Text] [Related]
15. Efflux of zidovudine and 2',3'-dideoxyinosine out of the cerebrospinal fluid when administered alone and in combination to Macaca nemestrina.
Tuntland T; Ravasco RJ; al-Habet S; Unadkat JD
Pharm Res; 1994 Feb; 11(2):312-7. PubMed ID: 8165194
[TBL] [Abstract][Full Text] [Related]
16. Zidovudine therapy and HIV type 1 mutations in children with symptomatic HIV type 1 infection: effect of switching to didanosine or zidovudine plus didanosine therapy. Italian Multicenter Study Group on HIV Mutations in Children.
Principi N; Marchisio P; Esposito S; Rossi P; Gattinara GC; Galli L; Gabiano C; Zuccotti GV; Orlandi P
AIDS Res Hum Retroviruses; 1998 Dec; 14(18):1653-9. PubMed ID: 9870319
[TBL] [Abstract][Full Text] [Related]
17. Frequency of Tk and Hprt lymphocyte mutants and bone marrow micronuclei in mice treated neonatally with zidovudine and didanosine.
Von Tungeln LS; Dobrovolsky VN; Bishop ME; Shaddock JG; Heflich RH; Beland FA
Mutagenesis; 2004 Jul; 19(4):307-11. PubMed ID: 15215330
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in children with HIV infection.
Gibb D; Barry M; Ormesher S; Nokes L; Seefried M; Giaquinto C; Back D
Br J Clin Pharmacol; 1995 May; 39(5):527-30. PubMed ID: 7669489
[TBL] [Abstract][Full Text] [Related]
19. Activities of 3'-azido-3'-deoxythymidine nucleotide dimers in primary lymphocytes infected with human immunodeficiency virus type 1.
Schinazi RF; Sommadossi JP; Saalmann V; Cannon DL; Xie MY; Hart GC; Smith GA; Hahn EF
Antimicrob Agents Chemother; 1990 Jun; 34(6):1061-7. PubMed ID: 2393266
[TBL] [Abstract][Full Text] [Related]
20. Influence of interleukin-3 (IL-3) on the hematopoietic toxicity associated with combination anti-viral drugs (zidovudine and DDI) in vitro using retrovirus-infected bone marrow cells.
Gallicchio VS; Hughes NK
Int J Immunopharmacol; 1994 Apr; 16(4):359-66. PubMed ID: 8045675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]